Stay updated on Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial

Sign up to get notified when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays the revision label as v3.5.4, replacing the previous v3.5.3. This change signals a newer release of the site’s components and may reflect updates to the underlying platform used by the page.
    Difference
    0.0%
    Check dated 2026-05-16T09:22:25.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page’s footer software/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3.”
    Difference
    0.0%
    Check dated 2026-04-24T17:13:51.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.5.2 supersedes v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-04-17T14:07:30.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    IgA glomerulonephritis was added as a listed condition, aligning with IgA nephropathy. This text update does not modify study design, eligibility criteria, or measured outcomes.
    Difference
    0.0%
    Check dated 2026-04-03T05:59:09.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T23:50:43.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Page revision history updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T20:15:52.000Z thumbnail image

Stay in the know with updates to Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.